Javascript is disabled in your browser

Startbase requires Javascript in order to display content.
Please check your browser settings and enable Javascript-Support for this website.

Synbiotic

News Synbiotic SE takes over parts of several hemp companies The startup paid €11.2 million for the deal, but it also allowed it to raise its revenue forecast for 2021 to €15 million.

Felix Leitmeyer 01.12.2021

News Synbiotic raises seven million euros The cannabis company has been listed on the German stock exchange since 2019. Now it has issued 334,000 new shares.

Sophie Deistler 28.10.2021

News Synbiotic launches CBD without hemp on the market The start-up extracts the cannabinoids from hops, among other things. This should make it possible to sell the CBD products even in countries that ban hemp.

Tom Schmidtgen 23.07.2021

News Synbiotic launches joint venture of beverage professionals Synbiotic is entering new spheres and founding a joint venture under the name Princess Stardurst, whose products are aimed primarily at the lifestyle market. Business angels are the Thomas Henry managing director and...

Lisa Marie Münster 29.06.2021

News Synbiotic acquires GECA Pharma The cannabinoid start-up is thus adding the next company to its group of companies. With this, Synbiotic is now also entering the market for medicinal cannabis.

Jan Schulte 20.05.2021

News Synbiotic invests in Canadian cannabinoid company The cannabinoid start-up has subscribed to a convertible bond in the amount of two million US dollars. There is also an option to acquire NeuroTheryX outright.

Jan Schulte 07.04.2021

News BGH ruling backs CBD start-ups According to a ruling by the Federal Supreme Court, the sale of CBD flowers to customers can be legal. However, a crucial restriction remains.

Jan Schulte 29.03.2021

1